Causes and management of portal hypertension in the pediatric population

Clinics in Liver Disease

Volumn 5, Issue 3, 2001, Pages 789-818

  Ryckman, Frederick C ^b   Alonso, Maria H ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FRESH FROZEN PLASMA; GLYCERYL TRINITRATE; HISTAMINE H2 RECEPTOR ANTAGONIST; ISOSORBIDE MONONITRATE; NADOLOL; OCTREOTIDE; OXYGEN; PROPRANOLOL; PROTON PUMP INHIBITOR; SOMATOSTATIN; VASODILATOR AGENT; VASOPRESSIN; VITAMIN K GROUP;

CRYOPRECIPITATE; DIAGNOSTIC PROCEDURE; ENDOSCOPIC THERAPY; ESOPHAGUS VARICES; GASTROINTESTINAL HEMORRHAGE; HEPATOPULMONARY SYNDROME; HUMAN; LIGATION; LIVER DISEASE; LIVER SINUSOID; LIVER TRANSPLANTATION; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PULMONARY HYPERTENSION; REVIEW; SCLEROTHERAPY; THROMBOSIS;

EID: 0034856043     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70192-6     Document Type: Article

References (89)

1. Portopulmonary shunt by splenopneumopexy as a surgical treatment of Budd-Chiari syndrome
2. Current concepts in pediatric liver transplant
3. Anatomy and etiology of extrahepatic portal vein obstruction in children leading to bleeding esophageal varices
4. Recurrent intestinal bleeding from jejunojejunostomy caused by portal hypertension following hepatoportojejunostomy in extra hepatic biliary atresia (EHBA)-successful treatment by transjugular intrahepatic portosystemic shunt (TIPS)
5. Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation
6. Transplantation for childhood liver disease: An overview
7. Biliary atresia: Current concepts and research directions. Summary of a symposium
8. Experience with the Rex shunt (mesenterico-left portal bypass) in children with extrahepatic portal hypertension
9. Decompression of portal hypertension in a child with cystic fibrosis after transjugular intrahepatic portosystemic shunt placement
10. Portal hypertension in children
11. Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: A meta-analysis
12. Split liver transplantation
13. Emergency transjugular intrahepatic portosystemic shunt (TIPS) in an infant: A case report
14. Hepatoportal sclerosis in childhood: A mimic of extrahepatic portal vein obstruction
15. Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial
16. The treatment of portal hypertension: A meta-analytic review
17. Outcome of cystic fibrosis-associated liver cirrhosis: Management of portal hypertension
18. Direct bypassing of extrahepatic portal venous obstruction in children: A new technique for combined hepatic portal revascularization and treatment of extrahepatic portal hypertension
19. Treatment of extrahepatic portal hypertension in children by mesenteric-to-left portal vein bypass: A new physiological procedure
20. Endoscopic sclerotherapy in children
21. C, protein S and antithrombin III in children with portal vein obstruction
22. Transjugular intrahepatic portosystemic stent shunt placement in a patient with cystic fibrosis complicated by portal hypertension
23. Endoscopic ligation of esophageal varices in children
24. H-type shunt with an autologous venous graft for treatment of portal hypertension in children
25. Randomized trial of variceal banding ligation versus injection sclerotherapy for bleeding esophageal varices
26. Prophylactic sclerotherapy in children with esophageal varices: Long-term results of a controlled prospective randomized trial
27. The use of extracorporeal life support in pediatric burn patients with respiratory failure
28. Long-term results of pediatric liver transplantation: An analysis of 569 transplants
29. Transjugular intrahepatic portosystemic shunt creation in children: Initial clinical experience
30. Post-surgical shunt hepatopulmonary syndrome in a case of non-cirrhotic portal hypertension: Lack of efficacy of shunt reversal
31. Distal splenorenal shunt with splenopancreatic disconnection for portal hypertension in biliary atresia
32. Role of transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension in pediatric patients
33. Transjugular intrahepatic portosystemic shunts (TIPS) in children
34. Endoscopic sclerotherapy for control of bleeding varices in children
35. Endoscopic injection sclerotherapy for esophagogastric variceal bleeding in children with biliary atresia
36. Assessment of injection sclerotherapy in the management of 152 children with oesophageal varices
37. Living donor liver transplantation: An 8-year experience with 379 consecutive cases
38. Propranolol for prophylaxis of bleeding in cirrhotic patients with large varices: A multicenter, randomized clinical trial
39. Transjugular portosystemic shunts in pediatric patients awaiting liver transplantation
40. Esophageal varices: Current management in children
41. Portosystemic shunting in children during the era of endoscopic therapy: Improved postoperative growth parameters
42. Transjugular intrahepatic portosystemic shunt in a child with cystic fibrosis
43. Detection of thrombosis in the portal venous system: Comparison of contrast-enhanced MR angiography with intraarterial digital subtraction angiography
44. Hepatopulmonary syndrome: Recent literature (1997 to 1999) and implications for liver transplantation
45. 99mTc MAA lung scanning
46. Use of adrenal vein conduit for splenorenal shunts: A case report
47. Treatment of bleeding stomal varices using transjugular intrahepatic portosystemic shunt
48. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis
49. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices
50. Early liver transplantation is crucial in children with liver disease and pulmonary artery hypertension
51. Risk of gastrointestinal bleeding during adolescence and early adulthood in children with portal vein obstruction
52. Treatment of portal hypertension in children
53. A technique for distal splenoadrenal shunting in pediatric portal hypertension
54. Transabdominal extensive esophagogastric devascularization with gastroesophageal stapling for management of noncirrhotic portal hypertension: Long-term results
55. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis
56. Long-term effects of distal splenorenal shunt with splenopancreatic and gastric disconnection on hypersplenism due to liver cirrhosis
57. Endoscopic variceal ligation in children
58. Congenital abnormalities associated with extrahepatic portal hypertension
59. Long-term prognosis of non-shunt operation for idiopathic portal hypertension
60. Treatment of bleeding esophagogastric varices due to extrahepatic portal hypertension: Results of portal-systemic shunts during 35 years
61. Is splenectomy necessary in devascularization procedures for treatment of bleeding portal hypertension?
62. Pediatric liver transplantation: From the full-size liver graft to reduced, split, and living related liver transplantation
63. Propranolol for primary and secondary prophylaxis of variceal bleeding in children with cirrhosis
64. Management of esophageal varices in children by endoscopic variceal ligation
65. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials
66. Splenopneumopexy to treat portal hypertension produced by venous occlusive disease
67. The role of portosystemic shunting in children in the transplant era
68. New issues concerning the etiology of an old problem
69. Portopulmonary shunt by splenopneumopexy for portal hypertension in children
70. Endoscopic variceal ligation in the management of gastroesophageal varices in postoperative biliary atresia
71. TIPS: A new therapy for esophageal variceal bleeding caused by EHBA
72. Transjugular intrahepatic portosystemic shunt in an infant
73. Propranolol in prevention of portal hypertensive hemorrhage in children: A pilot study
74. Portal hypertension
75. Portosystemic shunting for pediatric portal hypertension
76. Pulmonary hypertension associated with postoperative biliary atresia: Report of two cases
77. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices
78. Reversible hepatic veno-occlusive disease in an infant after consumption of pyrrolizidine-containing herbal tea
79. Emergency transjugular intrahepatic portosystemic shunt prior to liver transplantation
80. Long-term outcome after injection sclerotherapy for esophageal varices in children with extrahepatic portal hypertension
81. Causes of late mortality in pediatric liver transplant recipients
82. A modified Sugiura operation for bleeding varices in children
83. Endoscopic therapy in the management of esophageal varices: Injection sclerotherapy and variceal ligation
84. Endoscopic sclerotherapy of esophageal varices in infants and children
85. Portal-systemic encephalopathy in the noncirrhotic patient. Effect of portal-systemic shunting
86. Transjugular intrahepatic portosystemic shunt placement in a child complicated by perforated Roux-en-Y portoenterostomy
87. Bleeding stomal varices: Treatment with a transjugular intrahepatic portosystemic shunt in two pediatric patients
88. Endoscopic sclerotherapy for esophageal varices in children with extrahepatic portal venous obstruction: A follow-up study